Literature DB >> 10085399

Comparison of prognostic significance of nodal staging between old (4th edition) and new (5th edition) UICC TNM classification for gastric carcinoma. International Union Against Cancer.

C H Yoo1, S H Noh, Y I Kim, J S Min.   

Abstract

The description of nodal staging for gastric cancer was changed in the new fifth edition of the International Union Against Cancer (UICC) TNM classification from the anatomic sites of metastatic lymph nodes to the number of metastatic lymph nodes, as pN1 is metastasis in 1 to 6 lymph nodes, pN2 is in 7 to 15 lymph nodes, and pN3 is in 16 or more lymph nodes. The purpose of this study was to investigate the prognostic significance of the new staging system based on the number of metastatic lymph nodes compared to the old staging system by anatomic site. From 1987 to 1994 a total of 2108 patients who underwent potentially curative resections with D2 or D3 lymph node dissection and with 15 or more lymph nodes retrieved were studied retrospectively. Lymph node metastases were found in 1018 patients (48.3%). A mean of 37.9 lymph nodes were retrieved per patient, and a mean of 7.2 lymph nodes were invaded by tumor cells. We found that the new nodal staging based on the number of metastatic lymph nodes closely correlated with the depth of cancer invasion and with the old nodal staging based on the anatomic site of the metastatic nodes, with statistical significance. The 5-year survival rates after gastrectomy decreased significantly by increasing the extent of the pN classification in both nodal staging methods. In a subgroup analysis of survivals between the old and new nodal staging, the new classification showed more homogeneous survival at the same stage than the old one. With a multivariate analysis of prognostic factors, including the old and new nodal staging, the depth of invasion and the new nodal stage were the most significant prognostic factors, followed by the old nodal stage. Our data suggested that the new nodal staging based on the number of metastatic lymph nodes is not only a reliable and objective method for nodal classification, but it is also a significant prognostic determinant for gastric cancer that can be used in practice.

Entities:  

Mesh:

Year:  1999        PMID: 10085399     DOI: 10.1007/pl00012337

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  Alternating treatment with S-1 plus low-dose cisplatin and S-1 alone for advanced gastric cancer.

Authors:  Kazuhito Mita; Hideto Ito; Masato Fukumoto; Ryo Murabayashi; Kazuya Koizumi; Takashi Hayashi; Hiroyuki Kikuchi; Tadashi Kagaya
Journal:  J Gastrointest Surg       Date:  2011-03-10       Impact factor: 3.452

2.  Clinical significance of preoperative regional intra-arterial infusion chemotherapy for advanced gastric cancer.

Authors:  Cheng-Wu Zhang; Shou-Chun Zou; Dun Shi; Da-Jian Zhao
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

3.  Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer.

Authors:  Long-Bin Xiao; Jian-Xing Yu; Wen-Hui Wu; Feng-Feng Xu; Shi-Bin Yang
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

4.  Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma.

Authors:  O Cheong; S T Oh; B S Kim; J H Yook; J H Kim; J T Im; G C Park
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

5.  Long-term results of tailored D(2) lymph node dissection after R(0) surgery for gastric cancer.

Authors:  Marco Catarci; Leonardo Antonio Montemurro; Sabrina Ghinassi; Antonio Di Cintio; Leonardo Leone; Luigi Marino Cosentino; Maria Antonietta Viarengo; Giovanni Battista Grassi
Journal:  Updates Surg       Date:  2011-03-29

6.  Survival trends in gastric cancer patients of Northeast China.

Authors:  Hao Zhang; Ling-Ling Sun; Yan-Li Meng; Guang-Yu Song; Jing-Jing Hu; Ping Lu; Bin Ji
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

7.  Prognostic factors and availability of D2 lymph node dissection for the patients with stage II gastric cancer: comparative analysis of subgroups in stage II.

Authors:  Joong-Min Park; Jong-Han Kim; Sung-Soo Park; Seung-Joo Kim; Young-Jae Mok; Chong-Suk Kim
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

8.  Prognosis of pN3 stage gastric cancer.

Authors:  Jung Ryun Ahn; Minkyu Jung; Chan Kim; Min Hee Hong; Hong Jae Chon; Hye Ryun Kim; Hei-Cheul Jeung; Woo Jin Hyung; Sung Sook Lee; Hyun Cheol Chung; Sung Hoon Noh; Sun Young Rha
Journal:  Cancer Res Treat       Date:  2009-06-30       Impact factor: 4.679

9.  Distribution of solitary lymph nodes in primary gastric cancer: a retrospective study and clinical implications.

Authors:  Cai-Gang Liu; Ping Lu; Yang Lu; Feng Jin; Hui-Mian Xu; Shu-Bao Wang; Jun-Qing Chen
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

10.  Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution.

Authors:  Woo Jin Hyung; Sung Soo Kim; Won Hyuk Choi; Jae Ho Cheong; Seung Ho Choi; Choong Bai Kim; Sung Hoon Noh
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.